<?xml version="1.0" encoding="UTF-8"?>
<akn:akomaNtoso xmlns:akn="http://docs.oasis-open.org/legaldocml/ns/akn/3.0"><akn:act><akn:meta><akn:identification source="#cosilico"><akn:FRBRWork prescriptive="true" authoritative="true"><akn:FRBRuri value="/akn/us/usc/42/280b–1" /><akn:FRBRdate date="2025-12-31" name="retrieval" /><akn:FRBRauthor href="#us-congress" /><akn:FRBRcountry value="us" /></akn:FRBRWork><akn:FRBRExpression><akn:FRBRuri value="/akn/us/usc/42/280b–1/eng@2025" /><akn:FRBRdate date="2025-12-31" /><akn:FRBRauthor href="#cosilico" /><akn:FRBRlanguage language="en" /></akn:FRBRExpression><akn:FRBRManifestation><akn:FRBRuri value="/akn/us/usc/42/280b–1/eng@2025/main.xml" /><akn:FRBRdate date="2025-12-31" /><akn:FRBRauthor href="#cosilico" /></akn:FRBRManifestation></akn:identification></akn:meta><akn:body><akn:section eId="sec_280b_1"><akn:num>280b–1</akn:num><akn:heading>Preventing overdoses of controlled substances</akn:heading><akn:content><akn:p>§ 280b–1. Preventing overdoses of controlled substances(a) Evidence-based prevention grants(1) In generalThe Director of the Centers for Disease Control and Prevention may—(A) to the extent practicable, carry out and expand any evidence-based prevention activities described in paragraph (2);

(B) provide training and technical assistance to States, localities, and Indian Tribes for purposes of carrying out such activity; and

(C) award grants to States, localities, and Indian Tribes for purposes of carrying out such activity.


(2) Evidence-based prevention activitiesAn evidence-based prevention activity described in this paragraph is any of the following activities:(A) Improving the efficiency and use of a new or currently operating prescription drug monitoring program, including by—(i) encouraging all authorized users (as specified by the State or other entity) to register with and use the program;

(ii) enabling such users to access any updates to information collected by the program in as close to real-time as possible;

(iii) improving the ease of use of such program;

(iv) providing for a mechanism for the program to notify authorized users of any potential misuse or abuse of controlled substances and any detection of inappropriate prescribing or dispensing practices relating to such substances;

(v) encouraging the analysis of prescription drug monitoring data for purposes of providing de-identified, aggregate reports based on such analysis to State public health agencies, State substance abuse agencies, State licensing boards, and other appropriate State agencies, as permitted under applicable Federal and State law and the policies of the prescription drug monitoring program and not containing any protected health information, to prevent inappropriate prescribing, drug diversion, or abuse and misuse of controlled substances, and to facilitate better coordination among agencies;

(vi) enhancing interoperability between the program and any health information t</akn:p></akn:content><akn:subsection eId="subsec_280b_1_a"><akn:num>(a)</akn:num><akn:heading>Evidence-based prevention grants</akn:heading><akn:content><akn:p>(a) Evidence-based prevention grants</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_280b_1_b"><akn:num>(b)</akn:num><akn:heading>Enhanced controlled substance overdose data collection, analysis, and dissemination grants</akn:heading><akn:content><akn:p>(b) Enhanced controlled substance overdose data collection, analysis, and dissemination grants</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_280b_1_c"><akn:num>(c)</akn:num><akn:heading>Priority</akn:heading><akn:content><akn:p>(c) Priority In awarding grants to States under subsections (a) and (b), the Director of the Centers for Disease Control and Prevention may give priority to jurisdictions with a disproportionately high rate of drug overdoses or drug overdose deaths, as applicable.</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_280b_1_d"><akn:num>(d)</akn:num><akn:heading>Definitions</akn:heading><akn:content><akn:p>(d) Definitions In this section:</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_280b_1_e"><akn:num>(e)</akn:num><akn:heading>Authorization of appropriations</akn:heading><akn:content><akn:p>(e) Authorization of appropriations For purposes of carrying out this section, section 280g–3 of this title, and section 290bb–25g of this title, there is authorized to be appropriated $505,579,000 for each of fiscal years 2026 through 2030.</akn:p></akn:content></akn:subsection></akn:section></akn:body></akn:act></akn:akomaNtoso>